
Approve the pitch for Cortexa Biopharma
The pitch is written and waiting on your compliance sign-off — approve it and it can go out, or send it back with a note.
$260K
Today

Send the approved pitch to Quantum Oncology
Compliance cleared this pitch — it's ready to go out. Open it to review the final copy and send.
$280K
Ready

Re-engage Orion Vaccines
No activity in 16 days on a $365K deal sitting at "Qualified" — it's going cold. Draft a value nudge to bring it back.
$365K
Overdue
Quarter forecast
How the open book accumulated, what is likely to close, and the remaining quota gap.
Weighted commit
$1.4M
46% of quota
Best case
$3.1M
104% of quota
Gap to quota
$1.6M
Needs closing coverage
Open deals
10
2 currently at risk
Probability-adjusted revenue expected from each pipeline stage.
Best mix of confidence and value
| Customer | Primary Contact | Recommended Service | Status | Last Session | |
|---|---|---|---|---|---|
Northwind Biosciences | Owen Bradley Co-founder & COO | Clinical Trial Regulatory Support | — | Jul 20, 2026 • 1:01 PM | |
Quantum Oncology | Dr. Arun Pillai Chief Medical Officer | Clinical Trial Regulatory Support | Meeting Booked | Jul 19, 2026 • 2:36 PM | |
Helix Biologics | Dr. Lena Vogt SVP Global Regulatory | Global Labeling Strategy | Meeting Booked | Jul 18, 2026 • 5:25 PM | |
Solara Consumer Health | Megan Ruiz Compliance Manager | Labeling and Artwork Management | In Progress | Jul 16, 2026 • 1:37 PM | |
Cortexa Biopharma | Marcus Thorne Head of CMC | NDA/MAA CMC Writing | Interested | Jul 15, 2026 • 4:30 PM | |
BioNex Therapeutics | Dr. Priya Mehta VP Regulatory Affairs | Regulatory Submission Services | In Progress | Jul 15, 2026 • 12:00 PM |